SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Health Food

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2098111

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 2098111

Precision Biotics Market by Type (Precision Probiotics, Next-generation Probiotics, Synbiotics, Postbiotics), End Use Industry, Health/Functional Positioning, Distribution Channel, and Region - Global Forecast to 2031

PUBLISHED:
PAGES: 292 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The precision biotics market is estimated to record USD 4.91 billion in 2026 and reach USD 9.26 billion by 2031, at a CAGR of 13.5% from 2026 to 2031.

Scope of the Report
Years Considered for the Study2022-2031
Base Year2025
Forecast Period2026-2031
Units ConsideredValue (USD Million) and Volume (Tons)
SegmentsBy Type, End-use Industry, Health/Functional Positioning, Distribution Channel, and Region
Regions coveredNorth America, Europe, Asia Pacific, Rest of the World

"Gut & brain segment is driving market growth due to the rising focus on the gut-brain axis and personalized mental wellness solutions"

The gut & brain sub-segment under health/functional positioning is expected to witness the fastest growth in the precision biotics market owing to the growing awareness about the gut-brain axis and rising cases of stress, anxiety, depression, and other mental conditions. The ongoing developments in microbiome science, growing scientific evidence of the impact of gut microbiota on brain function, and the need for tailored solutions for improving mental wellness are leading to the rising use of precision biotics for gut and brain health.

Precision Biotics Market - IMG1

"E-commerce is driving market growth through expanding online retail and digital health platforms"

E-commerce is expected to become the fastest-growing route for distribution within the precision biotics market owing to the rising online purchasing trends and consumers' growing inclination toward easily available precision biotics products online. The development of online pharmacies, health and wellness platforms, as well as personalized offerings and recommendations, makes precision biotics more readily available, while competitive prices, broad product availability, and delivery at home keep boosting sales online.

"North America is expected to hold a significant share in the global precision biotics market owing to its advanced microbiome research ecosystem & strong industry presence"

North America holds the major share in the precision biotics market owing to the well-developed research ecosystem for microbiome, the presence of prominent precision biotics firms, and the use of personalized nutrition and preventive healthcare. Some other factors that contribute to the success of North America include the established healthcare infrastructure, rising awareness among consumers about gut health, innovations in microbiome, and access to clinically tested precision biotics.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the Precision Biotics market.

  • By Company Type: Tier 1 - 30%, Tier 2 - 25%, and Tier 3 - 45%
  • By Designation: CXOs - 25%, Managers - 35%, Others - 40%
  • By Region: North America - 20%, Europe - 30%, Asia Pacific - 35%, and Rest of the World - 5%

Prominent companies in the market include BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)- (Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), Infinant Health Inc (US), and others.

Research Coverage

This research report categorizes the precision biotics market by type (precision probiotics, next generation probiotics (NGPs), synbiotics, postbiotics), end-use industry (dietary supplements, functional food & beverages, pet supplements, pharmaceutical (OTC), infant formula, cosmetics, animal feed), health/functional positioning (digestive & gastrointestinal health, women's health, pediatric & infant health, skin health, gut & brain health, metabolic health, immune health, oral & dental health), distribution channel (pharmacies, retail, specialty stores, e-commerce, DTC subscription platforms), and region (North America, Europe, Asia Pacific, Rest of the World).

The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the Precision Biotics industry. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the Precision Biotics market. This report provides a competitive analysis of emerging startups in the Precision Biotics market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report

The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall precision biotics and its subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

  • Analysis of key drivers (Growing Adoption of Personalized & Targeted Nutrition and Microbiome-based Healthcare, Growing Incidence of Gastrointestinal Disorders), restraints (High Development Costs of Strain-Specific Precision Biotics, Complex Regulatory Pathways for Personalized Microbiome Products), opportunities (Increasing Partnerships Between Biotech Firms and Healthcare Providers, Rising Demand for Precision Nutrition in Chronic Disease Management), and challenges (Ensuring Strain Stability and Product Quality Across Supply Chains, Need for Robust Clinical Evidence to Support Health Claims)
  • Product Development/Innovation: Detailed insights into research & development activities and product launches in the precision biotics market
  • Market Development: Comprehensive information about lucrative markets-analysis of precision biotics across varied regions
  • Market Diversification: Exhaustive information about product sources, untapped geographies, recent developments, and investments in the precision biotics market
  • Competitive Assessment: In depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Darling Ingredients (US), Tessenderlo Group (Belgium) - BioGaia (Sweden), Novonesis Group (Denmark), Procter & Gamble (US), Unilever (UK), dsm-firmenich (Switzerland), Metagenics, LLC (US), Yakult Honsha Co., Ltd (Japan), Danone (France), KANEKA CORPORATION (Japan), Symrise (Germany)-(Probi), Jarrow Formulas, Inc (US), Pendulum (US), thegoodbug (India), Seed Health, Inc (US), Infinant Health Inc (US), and other players in the precision biotics market.
Show more
Product Code: FB 10562

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE AND SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
    • 1.3.2 CURRENCY CONSIDERED
    • 1.3.3 UNIT CONSIDERED
  • 1.4 STAKEHOLDERS

2 EXECUTIVE SUMMARY

  • 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
  • 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
  • 2.3 DISRUPTIVE TRENDS IN PRECISION BIOTICS MARKET
  • 2.4 HIGH-GROWTH SEGMENTS
  • 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

  • 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PRECISION BIOTICS MARKET
  • 3.2 PRECISION BIOTICS MARKET, BY TYPE AND REGION
  • 3.3 PRECISION BIOTICS MARKET, BY TOP THREE TYPES
  • 3.4 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL
  • 3.5 PRECISION BIOTICS MARKET, BY TOP FOUR HEALTH/ FUNCTIONAL POSITIONINGS
  • 3.6 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY
  • 3.7 PRECISION BIOTICS MARKET, BY COUNTRY

4 MARKET OVERVIEW

  • 4.1 INTRODUCTION
  • 4.2 MARKET DYNAMICS
    • 4.2.1 DRIVERS
      • 4.2.1.1 Growing adoption of personalized & targeted nutrition and microbiome-based healthcare
      • 4.2.1.2 Growing incidence of gastrointestinal disorders
      • 4.2.1.3 Growing consumer focus on preventive healthcare
    • 4.2.2 RESTRAINTS
      • 4.2.2.1 High development costs of strain-specific precision biotics
      • 4.2.2.2 Complex regulatory pathways for personalized microbiome products
    • 4.2.3 OPPORTUNITIES
      • 4.2.3.1 Increasing partnerships between biotech firms and healthcare providers
      • 4.2.3.2 Rising demand for precision nutrition in chronic disease management
      • 4.2.3.3 Growing integration of AI and multi-omics technologies in product development & advancement in the microbiome sequencing
    • 4.2.4 CHALLENGES
      • 4.2.4.1 Ensuring strain stability and product quality across supply chains
      • 4.2.4.2 Need for robust clinical evidence to support health claims
  • 4.3 UNMET NEEDS AND WHITE SPACES
    • 4.3.1 UNMET NEEDS IN PRECISION BIOTICS MARKET
    • 4.3.2 WHITE SPACE OPPORTUNITIES
  • 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
    • 4.4.1 INTERCONNECTED MARKETS
    • 4.4.2 CROSS-SECTOR OPPORTUNITIES
  • 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
    • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

  • 5.1 PORTER'S FIVE FORCES ANALYSIS
    • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.1.2 BARGAINING POWER OF SUPPLIERS
    • 5.1.3 BARGAINING POWER OF BUYERS
    • 5.1.4 THREAT OF SUBSTITUTES
    • 5.1.5 THREAT OF NEW ENTRANTS
  • 5.2 MACROECONOMIC OUTLOOK
    • 5.2.1 INTRODUCTION
    • 5.2.2 MACROECONOMIC INDICATORS
      • 5.2.2.1 Aging demographics fuel growth of north american probiotics market
      • 5.2.2.2 Increasing national healthcare expenditure
      • 5.2.2.3 Increasing prevalence of lifestyle-related chronic disorders
  • 5.3 VALUE CHAIN ANALYSIS
    • 5.3.1 RESEARCH & CONSUMER PRODUCT DEVELOPMENT
    • 5.3.2 INGREDIENT SOURCING & STRAIN DEVELOPMENT
    • 5.3.3 MANUFACTURING & PRODUCT FORMULATION
    • 5.3.4 DISTRIBUTION, RETAIL & SUPPLY CHAIN MANAGEMENT
    • 5.3.5 CONSUMER APPLICATIONS & COMMERCIALIZATION
  • 5.4 ECOSYSTEM/MARKET MAP ANALYSES
    • 5.4.1 DEMAND SIDE
    • 5.4.2 SUPPLY SIDE
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INTRODUCTION
    • 5.5.2 INDICATIVE PRICE TREND AMONG MARKET PLAYERS
    • 5.5.3 AVERAGE SELLING PRICE (ASP) TREND, BY REGION
    • 5.5.4 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022-2025 (USD/TONS)
  • 5.6 TRADE ANALYSIS
    • 5.6.1 IMPORT ANALYSIS: PRECISION BIOTICS
    • 5.6.2 EXPORT ANALYSIS: PRECISION BIOTICS
  • 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
  • 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.9 INVESTMENT AND FUNDING SCENARIO
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 PENDULUM - LAUNCH OF PENDULUM GLUCOSE CONTROL FOR PRECISION BLOOD SUGAR MANAGEMENT
    • 5.10.2 BIOGAIA - LAUNCH OF BIOGAIA PROTECTIS PLUS NEXT-GENERATION PATENTED PROBIOTIC DROPS
    • 5.10.3 FLORE (SUN GENOMICS) - DEVELOPMENT OF PRECISION SYNBIOTICS FOR AUTISM SPECTRUM DISORDER SUPPORT
    • 5.10.4 VIOME - LAUNCH OF VRX MY**BIOTICS TOOTHPASTE & GEL FOR PERSONALIZED ORAL MICROBIOME HEALTH
  • 5.11 IMPACT OF 2025 US TARIFF -PRECISION BIOTICS MARKET
    • 5.11.1 INTRODUCTION
    • 5.11.2 PRICE IMPACT ANALYSIS
    • 5.11.3 IMPACT ON COUNTRIES/REGIONS
      • 5.11.3.1 US
      • 5.11.3.2 Europe
      • 5.11.3.3 Asia Pacific
    • 5.11.4 IMPACT ON END USE INDUSTRIES

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

  • 6.1 TECHNOLOGY ANALYSIS
    • 6.1.1 KEY TECHNOLOGIES
      • 6.1.1.1 Next-generation sequencing (NGS)
      • 6.1.1.2 Precision fermentation & strain engineering
    • 6.1.2 COMPLEMENTARY ANALYSIS
      • 6.1.2.1 Microencapsulation & controlled release delivery systems
      • 6.1.2.2 Synbiotic formulation technologies
    • 6.1.3 ADJACENT TECHNOLOGIES
      • 6.1.3.1 Bioprocess automation & smart manufacturing
      • 6.1.3.2 Metabolomics platforms
  • 6.2 PATENT ANALYSIS
  • 6.3 FUTURE APPLICATIONS
    • 6.3.1 SMART (DISEASE-SENSING) PROBIOTICS: ENABLING THE NEXT GENERATION OF PRECISION BIOTICS
    • 6.3.2 ENGINEERED LIVE BIOTHERAPEUTICS: SHAPING THE FUTURE OF PRECISION BIOTICS
    • 6.3.3 ENGINEERED PRECISION PROBIOTICS FOR INFLAMMATORY BOWEL DISEASE (IBD): ADVANCING TARGETED MICROBIOME THERAPEUTICS
    • 6.3.4 POSTBIOTICS FOR NEXT-GENERATION FUNCTIONAL FOODS AND BIOPRESERVATION
  • 6.4 IMPACT OF GENERATIVE AI ON PRECISION BIOTICS MARKET
    • 6.4.1 INTRODUCTION
    • 6.4.2 TOP USE CASES AND MARKET POTENTIAL
    • 6.4.3 BEST PRACTICES IN PRECISION BIOTICS INDUSTRY
    • 6.4.4 CASE STUDIES OF AI IMPLEMENTATION IN THE PRECISION BIOTICS MARKET
    • 6.4.5 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
    • 6.4.6 CLIENTS' READINESS TO ADOPT GENERATIVE AI FOR PRECISION BIOTICS
  • 6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS

7 SUSTAINABILITY AND REGULATORY LANDSCAPE

  • 7.1 REGIONAL REGULATIONS AND COMPLIANCE
    • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 7.1.2 INDUSTRY STANDARDS
    • 7.1.3 LABELING REQUIREMENTS AND CLAIMS
    • 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
      • 7.1.4.1 Enhanced strain traceability and clinical evidence requirements
      • 7.1.4.2 Global harmonization of precision biotics regulations
      • 7.1.4.3 Stricter clinical validation and health claim compliance
      • 7.1.4.4 Digital traceability, AI-enabled quality monitoring, and compliance automation
      • 7.1.4.5 Higher quality standards for live biotherapeutic and next-generation biotics
  • 7.2 SUSTAINABILITY INITIATIVES
    • 7.2.1 SUSTAINABLE SOURCING
    • 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
    • 7.2.3 CIRCULAR ECONOMY APPROACHES
  • 7.3 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
  • 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

  • 8.1 DECISION-MAKING PROCESS
  • 8.2 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 8.2.2 BUYING CRITERIA
  • 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
  • 8.5 MARKET PROFITABILITY
  • 8.6 REVENUE POTENTIAL
    • 8.6.1 COST DYNAMICS
    • 8.6.2 MARGIN OPPORTUNITIES, BY TYPE

9 PRECISION BIOTICS MARKET, BY TYPE

  • 9.1 INTRODUCTION
  • 9.2 PRECISION PROBIOTICS
    • 9.2.1 PRECISION PROBIOTICS TO FUEL EXPANSION OF PRECISION BIOTICS MARKET
  • 9.3 NEXT-GENERATION PROBIOTICS
    • 9.3.1 NEXT-GENERATION PROBIOTICS DRIVING INNOVATION IN PRECISION BIOTICS MARKET
  • 9.4 SYNBIOTICS
    • 9.4.1 PERSONALIZED SYNBIOTICS DRIVING INNOVATION AND GROWTH IN PRECISION BIOTICS MARKET
  • 9.5 POSTBIOTICS
    • 9.5.1 COMMERCIALIZATION OF POSTBIOTIC PRODUCTS STRENGTHENING PRECISION BIOTICS MARKET

10 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY

  • 10.1 INTRODUCTION
  • 10.2 DIETARY SUPPLEMENTS
    • 10.2.1 GROWING DIETARY SUPPLEMENT ADOPTION DRIVING GLOBAL PRECISION BIOTICS GROWTH
  • 10.3 FUNCTIONAL FOOD & BEVERAGES
    • 10.3.1 GROWING DEMAND FOR FUNCTIONAL FOODS DRIVING PRECISION BIOTICS ADOPTION
  • 10.4 PET SUPPLEMENTS
    • 10.4.1 RISING PET HUMANIZATION DRIVING PRECISION BIOTICS ADOPTION IN COMPANION ANIMAL NUTRITION
  • 10.5 PHARMACEUTICALS (OTC)
    • 10.5.1 GROWING OTC SELF-CARE TRENDS ACCELERATING PRECISION BIOTICS ADOPTION
  • 10.6 INFANT FORMULA
    • 10.6.1 EARLY-LIFE NUTRITION INNOVATION DRIVING PRECISION BIOTICS ADOPTION IN INFANT FORMULA
  • 10.7 COSMETICS
    • 10.7.1 GROWING INVESTMENT IN MICROBIOME-BASED BEAUTY DRIVING PRECISION BIOTICS ADOPTION
  • 10.8 ANIMAL FEED
    • 10.8.1 SUSTAINABLE ANIMAL NUTRITION DRIVING PRECISION BIOTICS ADOPTION

11 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL

  • 11.1 INTRODUCTION
  • 11.2 PHARMACIES
    • 11.2.1 PHARMACIES ACCELERATING ADOPTION OF PRECISION BIOTICS ACROSS GLOBE
  • 11.3 RETAIL
    • 11.3.1 EXPANDING ORGANIZED RETAIL NETWORKS STRENGTHEN CONSUMER ACCESS TO PRECISION BIOTICS
  • 11.4 SPECIALTY STORES
    • 11.4.1 SPECIALTY HEALTH STORES ENHANCE CONSUMER ACCESS TO PRECISION BIOTICS GLOBALLY
  • 11.5 E-COMMERCE
    • 11.5.1 EXPANDING E-COMMERCE PLATFORMS ACCELERATE PRECISION BIOTICS ADOPTION GLOBALLY
  • 11.6 DTC SUBSCRIPTION PLATFORMS
    • 11.6.1 DIRECT-TO-CONSUMER (DTC) SUBSCRIPTION PLATFORMS EXPAND GLOBAL PRECISION BIOTICS ACCESSIBILITY

12 PRECISION BIOTICS MARKET, BY HEALTH/ FUNCTIONAL POSITIONING

  • 12.1 INTRODUCTION
  • 12.2 DIGESTIVE & GASTROINTESTINAL HEALTH
    • 12.2.1 MICROBIOME-BASED DIGESTIVE & GASTROINTESTINAL HEALTH SOLUTIONS ACCELERATING MARKET GROWTH
  • 12.3 WOMEN'S HEALTH
    • 12.3.1 ADVANCING WOMEN'S HEALTH THROUGH PRECISION MICROBIOME INNOVATION
  • 12.4 PEDIATRIC & INFANT HEALTH
    • 12.4.1 PEDIATRIC & INFANT HEALTH DRIVING GROWTH OF PRECISION BIOTICS MARKET
  • 12.5 SKIN HEALTH
    • 12.5.1 GROWING BURDEN OF SKIN DISORDERS DRIVING GLOBAL PRECISION BIOTICS ADOPTION
  • 12.6 GUT & BRAIN HEALTH
    • 12.6.1 GROWING MENTAL HEALTH BURDEN ACCELERATING PRECISION BIOTICS ADOPTION THROUGH GUT-BRAIN AXIS
  • 12.7 METABOLIC HEALTH
    • 12.7.1 GROWING BURDEN OF DIABETES AND PREDIABETES ACCELERATING PRECISION BIOTICS ADOPTION
  • 12.8 IMMUNE HEALTH
    • 12.8.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION
  • 12.9 ORAL & DENTAL HEALTH
    • 12.9.1 GROWING FOCUS ON PREVENTIVE IMMUNITY DRIVING GLOBAL PRECISION BIOTICS ADOPTION

13 PRECISION BIOTICS MARKET, BY REGION

  • 13.1 INTRODUCTION
  • 13.2 NORTH AMERICA
    • 13.2.1 US
      • 13.2.1.1 Growing government investments, precision nutrition initiatives, and strategic collaborations driving US precision biotics market
    • 13.2.2 CANADA
      • 13.2.2.1 Government investments, expanding genomics ecosystem and commercialization programs accelerating Canadian precision biotics market
  • 13.3 EUROPE
    • 13.3.1 GERMANY
      • 13.3.1.1 Precision Biotics Market Driven by Clinical Research and Personalized Nutrition
    • 13.3.2 UK
      • 13.3.2.1 Increasing Burden of Gastrointestinal Disorders Fueling Precision Biotics Demand
    • 13.3.3 FRANCE
      • 13.3.3.1 Growing Consumer Awareness and Personalized Nutrition Supporting Precision Biotics
    • 13.3.4 ITALY
      • 13.3.4.1 Strong Dietary Supplement Adoption Accelerates Precision Biotics Market Growth in Italy
    • 13.3.5 SPAIN
      • 13.3.5.1 Growing precision medicine and microbiome research drive Spain's precision biotics market
    • 13.3.6 REST OF EUROPE
  • 13.4 ASIA PACIFIC
    • 13.4.1 CHINA
      • 13.4.1.1 Expanding nutritional supplements industry accelerating precision biotics adoption in China
    • 13.4.2 INDIA
      • 13.4.2.1 Rising consumer awareness of gut health and preventive healthcare drives precision biotics market growth
    • 13.4.3 JAPAN
      • 13.4.3.1 Growing pharmaceutical investments support Japan's precision biotics market
    • 13.4.4 AUSTRALIA & NEW ZEALAND
      • 13.4.4.1 Advanced life sciences research and preventive healthcare drive the Australia & New Zealand precision biotics market
    • 13.4.5 REST OF ASIA PACIFIC
  • 13.5 REST OF THE WORLD (ROW)
    • 13.5.1 LATIN AMERICA
      • 13.5.1.1 Rising obesity and metabolic disorders drive precision biotics market growth
    • 13.5.2 MIDDLE EAST
      • 13.5.2.1 Expanding pharmaceutical manufacturing and precision medicine drive precision biotics market growth
    • 13.5.3 AFRICA
      • 13.5.3.1 Rising awareness of gut health and personalized nutrition supports market growth

14 COMPETITIVE LANDSCAPE

  • 14.1 OVERVIEW
  • 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 14.3 REVENUE ANALYSIS, 2023-2025
  • 14.4 MARKET SHARE ANALYSIS, 2025
  • 14.5 COMPANY VALUATION AND FINANCIAL METRICS
    • 14.5.1 COMPANY VALUATION
    • 14.5.2 EV/EBITDA
  • 14.6 BRAND COMPARISON ANALYSIS, BY TYPE
  • 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
    • 14.7.1 STARS
    • 14.7.2 EMERGING LEADERS
    • 14.7.3 PERVASIVE PLAYERS
    • 14.7.4 PARTICIPANTS
    • 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS
      • 14.7.5.1 Regional footprint
      • 14.7.5.2 Type footprint
      • 14.7.5.3 Function footprint
  • 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
    • 14.8.1 PROGRESSIVE COMPANIES
    • 14.8.2 RESPONSIVE COMPANIES
    • 14.8.3 DYNAMIC COMPANIES
    • 14.8.4 STARTING BLOCKS
    • 14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2025
      • 14.8.5.1 Detailed list of key startups/SMEs
      • 14.8.5.2 Competitive benchmarking of key startups/SMEs
  • 14.9 COMPETITIVE SCENARIO AND TRENDS
    • 14.9.1 PRODUCT LAUNCHES
    • 14.9.2 DEALS

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
    • 15.1.1 BIOGAIA
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products/Solutions/Services offered
      • 15.1.1.3 Recent developments
        • 15.1.1.3.1 Product launches
        • 15.1.1.3.2 Deals
      • 15.1.1.4 MnM view
        • 15.1.1.4.1 Key strengths
        • 15.1.1.4.2 Strategic choices
        • 15.1.1.4.3 Weaknesses & competitive threats
    • 15.1.2 NOVONESIS GROUP
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products/Solutions/Services offered
      • 15.1.2.3 Recent developments
        • 15.1.2.3.1 Deals
      • 15.1.2.4 MnM view
        • 15.1.2.4.1 Key strengths
        • 15.1.2.4.2 Strategic choices
        • 15.1.2.4.3 Weaknesses & competitive threats
    • 15.1.3 PROCTER & GAMBLE
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products/Solutions/Services offered
      • 15.1.3.3 MnM view
        • 15.1.3.3.1 Key strengths
        • 15.1.3.3.2 Strategic choices
        • 15.1.3.3.3 Weaknesses & competitive threats
    • 15.1.4 UNILEVER
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products/Solutions/Services offered
      • 15.1.4.3 Recent developments
        • 15.1.4.3.1 Product launches
      • 15.1.4.4 MnM view
        • 15.1.4.4.1 Key strengths
        • 15.1.4.4.2 Strategic choices
        • 15.1.4.4.3 Weaknesses & competitive threats
    • 15.1.5 DSM-FIRMENICH GROUP (CULTURELLE)
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products/Solutions/Services offered
        • 15.1.5.2.1 Deals
      • 15.1.5.3 MnM view
        • 15.1.5.3.1 Key strengths
        • 15.1.5.3.2 Strategic choices
        • 15.1.5.3.3 Weaknesses & competitive threats
    • 15.1.6 NESTLE (NESTLE HEALTH SCIENCE)
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products/Solutions/Services offered
      • 15.1.6.3 MnM view
    • 15.1.7 METAGENICS, LLC
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products/Solutions/Services offered
      • 15.1.7.3 Recent developments
        • 15.1.7.3.1 Deals
      • 15.1.7.4 MnM view
    • 15.1.8 YAKULT HONSHA CO., LTD.
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products/Solutions/Services offered
      • 15.1.8.3 Recent developments
        • 15.1.8.3.1 Product launches
      • 15.1.8.4 MnM view
    • 15.1.9 DANONE
      • 15.1.9.1 Business overview
      • 15.1.9.2 Products/Solutions/Services offered
      • 15.1.9.3 Recent developments
        • 15.1.9.3.1 Deals
      • 15.1.9.4 MnM view
    • 15.1.10 KANEKA CORPORATION (AB-BIOTICS)
      • 15.1.10.1 Business overview
      • 15.1.10.2 Products/Solutions/Services offered
      • 15.1.10.3 Recent developments
        • 15.1.10.3.1 Product launches
      • 15.1.10.4 MnM view
    • 15.1.11 SYMRISE GROUP (PROBI): BUSINESS OVERVIEW
      • 15.1.11.1 Products/Solutions/Services offered
      • 15.1.11.2 MnM view
    • 15.1.12 JARROW FORMULAS, INC
      • 15.1.12.1 Business overview
      • 15.1.12.2 Products/Solutions/Services offered
      • 15.1.12.3 MnM view
    • 15.1.13 PENDULUM
      • 15.1.13.1 Business overview
      • 15.1.13.2 Products/Solutions/Services offered
      • 15.1.13.3 Recent developments
        • 15.1.13.3.1 Product launches
      • 15.1.13.4 MnM view
    • 15.1.14 THE GOOD BUG
      • 15.1.14.1 Business overview
      • 15.1.14.2 Products/Solutions/Services offered
      • 15.1.14.3 MnM view
    • 15.1.15 SEED HEALTH INC
      • 15.1.15.1 Business overview
      • 15.1.15.2 Products/Solutions/Services offered
      • 15.1.15.3 MnM view
  • 15.2 OTHER PLAYERS
    • 15.2.1 INFINANT HEALTH INC.
      • 15.2.1.1 Business overview
      • 15.2.1.2 Products/Solutions/Services offered
      • 15.2.1.3 MnM view
    • 15.2.2 VIOME LIFE SCIENCES, INC.
      • 15.2.2.1 Business overview
      • 15.2.2.2 Products/Solutions/Services offered
        • 15.2.2.2.1 Product launches
      • 15.2.2.3 MnM view
    • 15.2.3 BLACKMORES
      • 15.2.3.1 Business overview
      • 15.2.3.2 Products/Solutions/Services offered
      • 15.2.3.3 MnM view
    • 15.2.4 LAYER ORIGIN NUTRITION
      • 15.2.4.1 Business overview
      • 15.2.4.2 Products/Solutions/Services offered
      • 15.2.4.3 Recent developments
      • 15.2.4.4 MnM view
    • 15.2.5 RESBIOTIC
      • 15.2.5.1 Business overview
      • 15.2.5.2 Products/Solutions/Services offered
      • 15.2.5.3 Recent developments
        • 15.2.5.3.1 Product launches
      • 15.2.5.4 MnM view
    • 15.2.6 FITBIOMICS
    • 15.2.7 FLORE INC
    • 15.2.8 ZBIOTICS
    • 15.2.9 BIOHM TECHNOLOGIES
    • 15.2.10 MRO MARYRUTH, LLC.

16 RESEARCH METHODOLOGY

  • 16.1 RESEARCH DATA
    • 16.1.1 SECONDARY DATA
      • 16.1.1.1 Key data from secondary sources
    • 16.1.2 PRIMARY DATA
      • 16.1.2.1 Key data from primary sources
      • 16.1.2.2 Breakdown of primary profiles
      • 16.1.2.3 Key insights from industry experts
  • 16.2 MARKET SIZE ESTIMATION
    • 16.2.1 TOP-DOWN APPROACH
    • 16.2.2 SUPPLY-SIDE ANALYSIS
    • 16.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
  • 16.3 DATA TRIANGULATION AND MARKET BREAKUP
  • 16.4 RESEARCH ASSUMPTIONS
  • 16.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT

17 ADJACENT AND RELATED MARKETS

  • 17.1 INTRODUCTION
  • 17.2 RESEARCH LIMITATIONS
  • 17.3 PROBIOTIC SUPPLEMENTS MARKET
    • 17.3.1 MARKET DEFINITION
    • 17.3.2 MARKET OVERVIEW
  • 17.4 PROBIOTICS MARKET
    • 17.4.1 MARKET DEFINITION
    • 17.4.2 MARKET OVERVIEW

18 APPENDIX

  • 18.1 DISCUSSION GUIDE
  • 18.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 18.3 CUSTOMIZATION OPTIONS
  • 18.4 RELATED REPORTS
  • 18.5 AUTHOR DETAILS
Show more
Product Code: FB 10562

List of Tables

  • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • TABLE 2 USD EXCHANGE RATES, 2021-2025
  • TABLE 3 INTERCONNECTED MARKETS
  • TABLE 4 PRECISION BIOTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 5 PRECISION BIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM)
  • TABLE 6 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022-2025 (USD/TON)
  • TABLE 7 AVERAGE SELLING PRICE (ASP) TREND BY TYPE, 2022-2025 (USD/TONS)
  • TABLE 8 TOP IMPORTERS OF PRECISION BIOTICS, 2022-2025 (USD)
  • TABLE 9 TOP EXPORTERS OF PRECISION BIOTICS, 2022-2025 (USD)
  • TABLE 10 PRECISION BIOTICS MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2026-2027
  • TABLE 11 PATENTS PERTAINING TO PRECISION BIOTICS MARKET, 2021-2026
  • TABLE 12 TOP USE CASES AND MARKET POTENTIAL
  • TABLE 13 BEST PRACTICES: COMPANIES IMPLEMENTING USE CASES
  • TABLE 14 PRECISION BIOTICS MARKET: CASE STUDIES RELATED TO GEN AI IMPLEMENTATION
  • TABLE 15 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 INTERNATIONAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 INDUSTRY STANDARDS IN PRECISION BIOTICS MARKET
  • TABLE 22 LABELING REQUIREMENTS AND CLAIMS IN PRECISION BIOTICS MARKET
  • TABLE 23 CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN PRECISION BIOTICS MARKET
  • TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
  • TABLE 25 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
  • TABLE 26 UNMET NEEDS IN PRECISION BIOTICS MARKET, BY APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
  • TABLE 27 COST DYNAMICS IN PRECISION MARKET
  • TABLE 28 MARGIN OPPORTUNITIES IN PRECISION BIOTICS MARKET, BY TYPE
  • TABLE 29 PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 30 PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 31 PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (TON)
  • TABLE 32 PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (TON)
  • TABLE 33 PRECISION PROBIOTICS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 34 PRECISION PROBIOTICS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 35 PRECISION PROBIOTICS MARKET, BY REGION, 2022-2025 (TONS)
  • TABLE 36 PRECISION PROBIOTICS MARKET, BY REGION, 2026-2031 (TONS)
  • TABLE 37 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 38 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 39 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2022-2025 (TONS)
  • TABLE 40 NEXT-GENERATION PROBIOTICS MARKET, BY REGION, 2026-2031 (TONS)
  • TABLE 41 SYNBIOTICS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 42 SYNBIOTICS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 43 SYNBIOTICS MARKET, BY REGION, 2022-2025 (TONS)
  • TABLE 44 SYNBIOTICS MARKET, BY REGION, 2026-2031 (TONS)
  • TABLE 45 POSTBIOTICS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 46 POSTBOTICS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 47 POSTBIOTICS MARKET, BY REGION, 2022-2025 (TONS)
  • TABLE 48 POSTBOTICS MARKET, BY REGION, 2026-2031 (TONS)
  • TABLE 49 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022-2025 (USD MILLION)
  • TABLE 50 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026-2031 (USD MILLION)
  • TABLE 51 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 52 PRECISION BIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 53 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 54 PRECISION BIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 55 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 56 PRECISION BIOTICS MARKET IN PET SUPPLEMENTS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 57 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC), BY REGION, 2022-2025 (USD MILLION)
  • TABLE 58 PRECISION BIOTICS MARKET IN PHARMACEUTICALS (OTC), BY REGION, 2026-2031 (USD MILLION)
  • TABLE 59 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 60 PRECISION BIOTICS MARKET IN INFANT FORMULA, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 61 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 62 PRECISION BIOTICS MARKET IN COSMETICS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 63 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 64 PRECISION BIOTICS MARKET IN ANIMAL FEED, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 65 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 66 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 67 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 68 PRECISION BIOTICS MARKET FROM PHARMACIES, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 69 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 70 PRECISION BIOTICS MARKET FROM RETAIL, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 71 PRECISION BIOTICS MARKET FROM SPECIALTY STORES, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 72 SPECIALTY STORES: PRECISION BIOTICS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 73 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 74 PRECISION BIOTICS MARKET FROM E-COMMERCE, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 75 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 76 PRECISION BIOTICS MARKET FROM DTC SUBSCRIPTION PLATFORMS, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 77 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022-2025 (USD MILLION)
  • TABLE 78 PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026-2031 (USD MILLION)
  • TABLE 79 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 80 PRECISION BIOTICS MARKET FOR DIGESTIVE & GASTROINTESTINAL HEALTH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 81 PRECISION BIOTICS MARKET FOR WOMEN'S HEALTH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 82 PRECISION BIOTICS MARKET FOR WOMEN'S HEALTH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 83 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 84 PRECISION BIOTICS MARKET FOR PEDIATRIC AND INFANT HEALTH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 85 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 86 PRECISION BIOTICS MARKET FOR SKIN HEALTH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 87 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 88 PRECISION BIOTICS MARKET FOR GUT & BRAIN HEALTH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 89 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 90 PRECISION BIOTICS MARKET FOR METABOLIC HEALTH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 91 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 92 PRECISION BIOTICS MARKET FOR IMMUNE HEALTH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 93 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 94 PRECISION BIOTICS MARKET FOR ORAL & DENTAL HEALTH, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 95 PRECISION BIOTICS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 96 PRECISION BIOTICS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 97 PRECISION BIOTICS MARKET, BY REGION, 2022-2025 (TON)
  • TABLE 98 PRECISION BIOTICS MARKET, BY REGION, 2026-2031 (TON)
  • TABLE 99 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 100 NORTH AMERICA: PRECISION BIOTICS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 101 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 102 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 103 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (TON)
  • TABLE 104 NORTH AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (TON)
  • TABLE 105 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022-2025 (USD MILLION)
  • TABLE 106 NORTH AMERICA: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026-2031 (USD MILLION)
  • TABLE 107 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022-2025 (USD MILLION)
  • TABLE 108 NORTH AMERICA: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026-2031 (USD MILLION)
  • TABLE 109 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 110 NORTH AMERICA: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 111 US: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 112 US: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 113 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 114 CANADA: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 115 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 116 EUROPE: PRECISION BIOTICS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 117 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 118 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 119 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (TON)
  • TABLE 120 EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (TON)
  • TABLE 121 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022-2025 (USD MILLION)
  • TABLE 122 EUROPE: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026-2031 (USD MILLION)
  • TABLE 123 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2022-2025 (USD MILLION)
  • TABLE 124 EUROPE: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026-2031 (USD MILLION)
  • TABLE 125 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 126 EUROPE: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 127 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 128 GERMANY: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 129 UK: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 130 UK: PRECISION BIOTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 131 FRANCE: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 132 FRANCE: PRECISION BIOTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 133 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 134 ITALY: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 135 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2022-2025 (USD MILLION)
  • TABLE 136 SPAIN: PRECISION BIOTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 137 REST OF EUROPE: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 138 REST OF EUROPE: PRECISION BIOTICS MARKET, BY APPLICATION, 2026-2031 (USD MILLION)
  • TABLE 139 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY, 2022-2025 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY COUNTRY, 2026-2031 (USD MILLION)
  • TABLE 141 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (TON)
  • TABLE 144 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (TON)
  • TABLE 145 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY, 2022-2025 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: PRECISION BIOTICS MARKET, END-USE INDUSTRY, 2026-2031 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022-2025 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026-2031 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: PRECISION BIOTICS MARKET, DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 151 CHINA: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 152 CHINA: PRECISION BIOTICS MARKET, BY TYPE 2026-2031 (USD MILLION)
  • TABLE 153 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 154 INDIA: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 155 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 156 JAPAN: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 157 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 158 AUSTRALIA & NEW ZEALAND: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 159 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 160 REST OF ASIA PACIFIC: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 161 ROW: PRECISION BIOTICS MARKET, BY REGION, 2022-2025 (USD MILLION)
  • TABLE 162 ROW: PRECISION BIOTICS MARKET, BY REGION, 2026-2031 (USD MILLION)
  • TABLE 163 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 164 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 165 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (TON)
  • TABLE 166 ROW: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (TON)
  • TABLE 167 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2022-2025 (USD MILLION)
  • TABLE 168 ROW: PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026-2031 (USD MILLION)
  • TABLE 169 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2022-2025 (USD MILLION)
  • TABLE 170 ROW: PRECISION BIOTICS MARKET, BY HEALTH/FUNCTIONAL POSITIONING, 2026-2031 (USD MILLION)
  • TABLE 171 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2022-2025 (USD MILLION)
  • TABLE 172 ROW: PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026-2031 (USD MILLION)
  • TABLE 173 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 174 LATIN AMERICA: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 175 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 176 MIDDLE EAST: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 177 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2022-2025 (USD MILLION)
  • TABLE 178 AFRICA: PRECISION BIOTICS MARKET, BY TYPE, 2026-2031 (USD MILLION)
  • TABLE 179 OVERVIEW OF STRATEGIES ADOPTED BY KEY PRECISION BIOTICS MANUFACTURER
  • TABLE 180 PRECISION BIOTICS MARKET: DEGREE OF COMPETITION
  • TABLE 181 PRECISION BIOTICS MARKET: REGIONAL FOOTPRINT, 2025
  • TABLE 182 PRECISION BIOTICS MARKET: TYPE FOOTPRINT, 2025
  • TABLE 183 PRECISION BIOTICS MARKET: FUNCTION FOOTPRINT, 2025
  • TABLE 184 PRECISION BIOTIC MARKET: DETAILED LIST OF KEY STARTUPS/SMES, 2025
  • TABLE 185 PRECISION BIOTIC: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025
  • TABLE 186 PRECISION BIOTICS MARKET: PRODUCT LAUNCHES, NOVEMBER 2021-JUNE 2026
  • TABLE 187 PRECISION BIOTICS MARKET: DEALS, NOVEMBER 2021-JUNE 2026
  • TABLE 188 BIOGAIA: COMPANY OVERVIEW
  • TABLE 189 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 190 BIOGAIA: PRODUCT LAUNCHES
  • TABLE 191 BIOGAIA: DEALS
  • TABLE 192 NOVONESIS GROUP: COMPANY OVERVIEW
  • TABLE 193 NOVONESIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 194 NOVONESIS GROUP: DEALS
  • TABLE 195 PROCTER & GAMBLE (P&G).: COMPANY OVERVIEW
  • TABLE 196 PROCTER & GAMBLE (P&G).: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 197 UNILEVER: COMPANY OVERVIEW
  • TABLE 198 UNILEVER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 199 UNILEVER: PRODUCT LAUNCHES
  • TABLE 200 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY OVERVIEW
  • TABLE 201 DSM-FIRMENICH GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 202 DSM-FIRMENICH GROUP (CULTURELLE): DEALS
  • TABLE 203 NESTLE: COMPANY OVERVIEW
  • TABLE 204 NESTLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 205 METAGENICS LLC: COMPANY OVERVIEW
  • TABLE 206 METAGENICS LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 207 METAGENICS LLC: DEALS
  • TABLE 208 YAKULT HONSHA CO., LTD.: COMPANY OVERVIEW
  • TABLE 209 YAKULT HONSHA CO., LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 210 YAKULT HONSHA CO., LTD: PRODUCT LAUNCHES
  • TABLE 211 DANONE: COMPANY OVERVIEW
  • TABLE 212 DANONE.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 213 DANONE: DEALS
  • TABLE 214 KANEKA CORPORATION (AB-BIOTICS): COMPANY OVERVIEW
  • TABLE 215 KANEKA CORPORATION (AB-BIOTICS): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 216 KANEKA CORPORATION (AB-BIOTICS): PRODUCT LAUNCHES
  • TABLE 217 SYMRISE GROUP (PROBI): COMPANY OVERVIEW
  • TABLE 218 SYMRISE GROUP (PROBI): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 219 JARROW FORMULAS INC: COMPANY OVERVIEW
  • TABLE 220 JARROW FORMULAS INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 221 PENDULUM: COMPANY OVERVIEW
  • TABLE 222 PENDULUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 223 PENDULUM: PRODUCT LAUNCHES
  • TABLE 224 THE GOOD BUG: COMPANY OVERVIEW
  • TABLE 225 THE GOOD BUG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 226 SEED HEALTH INC.: COMPANY OVERVIEW
  • TABLE 227 SEED HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 228 INFINANT HEALTH INC.: COMPANY OVERVIEW
  • TABLE 229 INFINANT HEALTH INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 230 VIOME LIFE SCIENCES, INC.: COMPANY OVERVIEW
  • TABLE 231 VIOME LIFE SCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 232 VIOME LIFE SCIENCES, INC: PRODUCT LAUNCHES
  • TABLE 233 BLACKMORES: COMPANY OVERVIEW
  • TABLE 234 BLACKMORES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 235 LAYER ORIGIN NUTRITION: COMPANY OVERVIEW
  • TABLE 236 LAYER ORIGIN NUTRITION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 237 RESBIOTIC: COMPANY OVERVIEW
  • TABLE 238 RESBIOTIC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 239 RESTBIOTIC: PRODUCT LAUNCHES
  • TABLE 240 KEY DATA FROM PRIMARY SOURCES
  • TABLE 241 MARKETS ADJACENT TO PRECISION BIOTICS MARKET
  • TABLE 242 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2022-2025 (USD MILLION)
  • TABLE 243 PROBIOTIC SUPPLEMENTS MARKET, BY INGREDIENT, 2026-2031 (USD MILLION)
  • TABLE 244 PROBIOTICS MARKET, BY END USER, 2020-2023 (USD BILLION)
  • TABLE 245 PROBIOTICS MARKET, BY END USER, 2024-2029 (USD BILLION)

List of Figures

  • FIGURE 1 MARKETS COVERED AND REGIONAL SCOPE
  • FIGURE 2 STUDY YEARS CONSIDERED
  • FIGURE 3 MARKET SCENARIO
  • FIGURE 4 PRECISION BIOTICS MARKET, 2022-2031 (USD BILLION)
  • FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PRECISION BIOTICS MARKET, 2022-JUNE 2026
  • FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PRECISION BIOTICS MARKET
  • FIGURE 7 PRECISION BIOTICS MARKET: HIGH-GROWTH SEGMENTS, 2026-2031
  • FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 9 INCREASING CONSUMER FOCUS ON GUT HEALTH AND PREVENTIVE HEALTHCARE TO ACCELERATE GROWTH OPPORTUNITIES IN PRECISION BIOTICS MARKET
  • FIGURE 10 PRECISION PROBIOTICS TYPE SEGMENT AND NORTH AMERICA REGION TO ACCOUNT FOR LARGEST MARKET SHARES IN 2026
  • FIGURE 11 PRECISION PROBIOTICS TYPE SEGMENT TO LEAD MARKET IN 2026
  • FIGURE 12 PHARMACIES SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 13 DIGESTIVE & GASTROINTESTINAL HEALTH SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 14 DIETARY SUPPLEMENTS END-USE INDUSTRY SEGMENT TO DOMINATE MARKET IN 2026
  • FIGURE 15 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2026
  • FIGURE 16 PRECISION BIOTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 PRECISION BIOTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 18 NATIONAL HEALTH EXPENDITURE PER CAPITA IN US FROM 2020 TO 2024
  • FIGURE 19 PRECISION BIOTIC MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 20 PRECISION BIOTICS MARKET ECOSYSTEM MAP
  • FIGURE 21 AVERAGE SELLING PRICE (ASP) TREND, BY REGION, 2022-2025 (USD/TON)
  • FIGURE 22 IMPORT OF HS CODE 300249, BY KEY COUNTRY, 2022-2025 (USD)
  • FIGURE 23 EXPORT OF HS CODE 300249, BY KEY COUNTRY, 2022-2025 (USD)
  • FIGURE 24 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS' BUSINESSES
  • FIGURE 25 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 26 NUMBER OF PATENTS GRANTED BETWEEN 2016 AND 2026
  • FIGURE 27 FUTURE APPLICATIONS
  • FIGURE 28 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
  • FIGURE 29 PRECISION BIOTICS MARKET DECISION-MAKING FACTORS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT TYPES
  • FIGURE 31 KEY BUYING CRITERIA FOR TOP PRODUCT TYPES
  • FIGURE 32 ADOPTION BARRIERS AND INTERNAL CHALLENGES
  • FIGURE 33 PRECISION BIOTICS MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
  • FIGURE 34 PRECISION BIOTICS MARKET, BY END-USE INDUSTRY, 2026 VS. 2031 (USD MILLION)
  • FIGURE 35 PRECISION BIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2026 VS. 2031 (USD MILLION)
  • FIGURE 36 PRECISION BIOTICS MARKET, BY HEALTH & FUNCTIONAL POSITIONING, 2026 VS. 2031 (USD MILLION)
  • FIGURE 37 PRECISION BIOTICS MARKET, BY KEY COUNTRY, 2026-2031 (USD MILLION)
  • FIGURE 38 NORTH AMERICA: PRECISION BIOTICS MARKET SNAPSHOT
  • FIGURE 39 ASIA PACIFIC: PRECISION BIOTICS MARKET SNAPSHOT
  • FIGURE 40 REVENUE ANALYSIS FOR KEY COMPANIES, 2023-2025 (USD BILLION)
  • FIGURE 41 SHARE OF LEADING COMPANIES IN PRECISION BIOTICS MARKET, 2025
  • FIGURE 42 COMPANY VALUATION OF PRECISION BIOTICS MANUFACTURERS, 2025
  • FIGURE 43 EV/EBITDA OF KEY COMPANIES, 2025
  • FIGURE 44 BRAND/PRODUCT/SERVICE ANALYSIS, BY KEY PLAYERS OF PRECISION BIOTICS MARKET
  • FIGURE 45 PRECISION BIOTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
  • FIGURE 46 PRECISION BIOTICS MARKET: COMPANY FOOTPRINT, 2025
  • FIGURE 47 PRECISION BIOTIC MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
  • FIGURE 48 BIOGAIA: COMPANY SNAPSHOT
  • FIGURE 49 NOVONESIS GROUP: COMPANY SNAPSHOT
  • FIGURE 50 PROCTER & GAMBLE (P&G): COMPANY SNAPSHOTS
  • FIGURE 51 UNILEVER: COMPANY SNAPSHOTS
  • FIGURE 52 DSM-FIRMENICH GROUP (CULTURELLE): COMPANY SNAPSHOT
  • FIGURE 53 NESTLE: COMPANY SNAPSHOT
  • FIGURE 54 YAKULT HONSHA CO., LTD: COMPANY SNAPSHOT
  • FIGURE 55 DANONE: COMPANY SNAPSHOT
  • FIGURE 56 AB-BIOTICS (SUBSIDIARY OF KANEKA COMPANY): COMPANY SNAPSHOT
  • FIGURE 57 SYMRISE GROUP (PROBI): SNAPSHOT
  • FIGURE 58 PRECISION BIOTICS MARKET: RESEARCH DESIGN
  • FIGURE 59 KEY DATA FROM SECONDARY SOURCES
  • FIGURE 60 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 61 KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 62 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 63 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP
  • FIGURE 64 PRECISION BIOTICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 65 DATA TRIANGULATION
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!